Insiders who reported open-market trades in the last 12 months at the companies Aziz Sawaf files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Eli Samaha - $5.91M in TBPH purchases and sales in the last 12 months
Eran Broshy - $1.66M in TBPH purchases and sales in the last 12 months
Rhonda Farnum - $1.46M in TBPH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Aziz Sawaf is a corporate insider, tracked as SVP & CHIEF FINANCIAL OFFICER of Theravance Biopharma, Inc. (TBPH). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Aziz Sawaf submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Aziz Sawaf is SVP & CHIEF FINANCIAL OFFICER of Theravance Biopharma, Inc. (TBPH). 8 SEC Form 4 filings on record going back to 2024, most recently on 25 September 2026.
Recent transactions
10
The latest 10 SEC Form 4 transactions reported by Aziz Sawaf.
InsiderAlpha's records for Aziz Sawaf go back to 2024: 8 primary Form 4 filings, an average of 2.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
